BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28194941)

  • 1. Rate of Asparagine Deamidation in a Monoclonal Antibody Correlating with Hydrogen Exchange Rate at Adjacent Downstream Residues.
    Phillips JJ; Buchanan A; Andrews J; Chodorge M; Sridharan S; Mitchell L; Burmeister N; Kippen AD; Vaughan TJ; Higazi DR; Lowe D
    Anal Chem; 2017 Feb; 89(4):2361-2368. PubMed ID: 28194941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure Based Prediction of Asparagine Deamidation Propensity in Monoclonal Antibodies.
    Yan Q; Huang M; Lewis MJ; Hu P
    MAbs; 2018; 10(6):901-912. PubMed ID: 29958069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of asparagine 330 deamidation in an Fc-fragment of IgG1 using cation exchange chromatography and peptide mapping.
    Zhang YT; Hu J; Pace AL; Wong R; Wang YJ; Kao YH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Aug; 965():65-71. PubMed ID: 24999246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asparagine deamidation dependence on buffer type, pH, and temperature.
    Pace AL; Wong RL; Zhang YT; Kao YH; Wang YJ
    J Pharm Sci; 2013 Jun; 102(6):1712-1723. PubMed ID: 23568760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous assessment of Asp isomerization and Asn deamidation in recombinant antibodies by LC-MS following incubation at elevated temperatures.
    Diepold K; Bomans K; Wiedmann M; Zimmermann B; Petzold A; Schlothauer T; Mueller R; Moritz B; Stracke JO; Mølhøj M; Reusch D; Bulau P
    PLoS One; 2012; 7(1):e30295. PubMed ID: 22272329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo deamidation characterization of monoclonal antibody by LC/MS/MS.
    Huang L; Lu J; Wroblewski VJ; Beals JM; Riggin RM
    Anal Chem; 2005 Mar; 77(5):1432-9. PubMed ID: 15732928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of IgG1 Fc Deamidation at Asparagine 325 and Its Impact on Antibody-dependent Cell-mediated Cytotoxicity and FcγRIIIa Binding.
    Lu X; Machiesky LA; De Mel N; Du Q; Xu W; Washabaugh M; Jiang XR; Wang J
    Sci Rep; 2020 Jan; 10(1):383. PubMed ID: 31941950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of protein structure on deamidation rate in the Fc fragment of an IgG1 monoclonal antibody.
    Sinha S; Zhang L; Duan S; Williams TD; Vlasak J; Ionescu R; Topp EM
    Protein Sci; 2009 Aug; 18(8):1573-84. PubMed ID: 19544580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Method to differentiate asn deamidation that occurred prior to and during sample preparation of a monoclonal antibody.
    Gaza-Bulseco G; Li B; Bulseco A; Liu HC
    Anal Chem; 2008 Dec; 80(24):9491-8. PubMed ID: 19072263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid Prediction of Deamidation Rates of Proteins to Assess Their Long-Term Stability Using Hydrogen Exchange-Mass Spectrometry.
    Gamage CLD; Hageman TS; Weis DD
    J Pharm Sci; 2019 Jun; 108(6):1964-1972. PubMed ID: 30684538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of deamidation and isomerization sites on pharmaceutical recombinant antibody using H(2)(18)O.
    Terashima I; Koga A; Nagai H
    Anal Biochem; 2007 Sep; 368(1):49-60. PubMed ID: 17617368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput screening of antibody variants for chemical stability: identification of deamidation-resistant mutants.
    DiCara DM; Andersen N; Chan R; Ernst JA; Ayalon G; Lazar GA; Agard NJ; Hilderbrand A; Hötzel I
    MAbs; 2018 Oct; 10(7):1073-1083. PubMed ID: 30130444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific catalysis of asparaginyl deamidation by carboxylic acids: kinetic, thermodynamic, and quantitative structure-property relationship analyses.
    Connolly BD; Tran B; Moore JM; Sharma VK; Kosky A
    Mol Pharm; 2014 Apr; 11(4):1345-58. PubMed ID: 24620787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asparagine Deamidation in a Complementarity Determining Region of a Recombinant Monoclonal Antibody in Complex with Antigen.
    Nowak C; Tiwari A; Liu H
    Anal Chem; 2018 Jun; 90(11):6998-7003. PubMed ID: 29712431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of asparagine deamidation in the light chain CDR1 of a humanized IgG1 antibody.
    Vlasak J; Bussat MC; Wang S; Wagner-Rousset E; Schaefer M; Klinguer-Hamour C; Kirchmeier M; Corvaïa N; Ionescu R; Beck A
    Anal Biochem; 2009 Sep; 392(2):145-54. PubMed ID: 19497295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of deamidation artifacts induced by microwave-assisted tryptic digestion of a monoclonal antibody.
    Formolo T; Heckert A; Phinney KW
    Anal Bioanal Chem; 2014 Oct; 406(26):6587-98. PubMed ID: 25080027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary structure and protein deamidation.
    Xie M; Schowen RL
    J Pharm Sci; 1999 Jan; 88(1):8-13. PubMed ID: 9874696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein asparagine deamidation prediction based on structures with machine learning methods.
    Jia L; Sun Y
    PLoS One; 2017; 12(7):e0181347. PubMed ID: 28732052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting deamidation and isomerization sites in therapeutic antibodies using structure-based
    Hoffmann D; Bauer J; Kossner M; Henry A; Karow-Zwick AR; Licari G
    MAbs; 2024; 16(1):2333436. PubMed ID: 38546837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometric analysis of asparagine deamidation and aspartate isomerization in polypeptides.
    Yang H; Zubarev RA
    Electrophoresis; 2010 Jun; 31(11):1764-72. PubMed ID: 20446295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.